From: Effects of metabolic parameters’ variability on cardiovascular outcomes in diabetic patients
Univariable | Final multivariable model | |||
---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | |
Age | 1.02 (1.01–1.03) | < 0.01 | 1.01 (1.01–1.02) | < 0.01 |
Male sex | 1.74 (1.52-2.00) | < 0.01 | 1.35 (1.17–1.56) | < 0.01 |
Smoking | 1.65 (1.01–1.03) | < 0.01 | ||
Creatinine | 1.17 (1.15–1.20) | < 0.01 | 1.10 (1.07–1.14) | < 0.01 |
Hypertension | 2.67 (2.13–3.33) | < 0.01 | ||
Dyslipidemia | 1.96 (1.47–2.61) | < 0.01 | ||
Prior MI | 23.65 (20.76–26.93) | < 0.01 | 19.57 (17.09–22.40) | < 0.01 |
Prior stroke | 1.50 (1.28–1.76) | < 0.01 | ||
Risk score (high risk) | 1.91 (1.60–2.27) | < 0.01 | ||
Risk score (very high risk) | 2.86 (2.41–3.39) | < 0.01 | ||
Baseline SBP | 1.01 (1.00-1.01) | 0.024 | ||
Baseline TC | 1.00 (0.99-1.00) | 0.875 | 1.45 (1.25–1.68) | < 0.01 |
Baseline TG | 1.00 (1.00–1.00) | < 0.01 | ||
Baseline glucose | 1.00 (1.00–1.00) | < 0.01 | ||
High SBP-CV | 2.43 (2.11–2.79) | < 0.01 | 1.79 (1.54–2.07) | < 0.01 |
High TC-CV | 1.83 (1.50–2.06) | < 0.01 | 1.54 (1.34–1.77) | < 0.01 |
High TG-CV | 1.23 (0.85–1.97) | < 0.01 | 1.15 (1.01–1.31) | 0.040 |
High glucose-CV | 2.13 (1.55–2.27) | < 0.01 | 1.61 (1.40–1.86) | < 0.01 |
High mean SBP | 0.99 (0.88–1.13) | 0.935 | ||
High mean TC | 0.55 (0.48–0.63) | < 0.01 | 0.62 (0.53–0.73) | < 0.01 |
High mean TG | 1.19 (1.05–1.35) | < 0.01 | ||
High mean glucose | 1.33 (1.17–1.52) | < 0.01 | ||
Anti-hypertensive drug | 3.79 (2.97–4.82) | < 0.01 | 1.74 (1.35–2.24) | < 0.01 |
Statin | 1.72 (1.43–2.08) | < 0.01 | ||
Insulin | 1.60 (1.41–1.82) | < 0.01 |